Catalent to acquire gene-therapy service firm Paragon
Saturday, April 20, 2019 - 07:00
in Mathematics & Economics
The $1.2 billion deal is the latest designed to support the flood of gene therapies in development
The $1.2 billion deal is the latest designed to support the flood of gene therapies in development